Skip to Content

Kaya Holdings Inc KAYS

Morningstar Rating
$0.04 −0.01 (12.53%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KAYS is trading at a 687% premium.
Price
$0.04
Fair Value
$7.90
Uncertainty
Extreme
1-Star Price
$2.90
5-Star Price
$6.33
Economic Moat
Htq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KAYS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.04
Day Range
$0.040.04
52-Week Range
$0.030.06
Bid/Ask
$0.04 / $0.05
Market Cap
$866,957.85
Volume/Avg
1,628 / 12,548

Key Statistics

Price/Earnings (Normalized)
Price/Sales
44.23
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Kaya Holdings Inc is a holding company. It is focusing on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company own and operate a medical cannabis dispensary in the United States. Its has produced, distributed, and/or sold a full range of premium cannabis products including flower, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
19

Valuation

Metric
KAYS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
44.23
Price/Cash Flow
Price/Earnings
KAYS

Financial Strength

Metric
KAYS
Quick Ratio
0.01
Current Ratio
0.02
Interest Coverage
1.58
Quick Ratio
KAYS

Profitability

Metric
KAYS
Return on Assets (Normalized)
−871.78%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
KAYS
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
HbkmrvttcJcnv$81.9 Bil
Merck KGaA ADR
MKKGY
TwwhbchfqFjgvxkj$71.1 Bil
Haleon PLC ADR
HLN
CrzccdrnPmn$39.8 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
DqxmzndskQmqp$19.3 Bil
Viatris Inc
VTRS
TrdpyvjhHbcq$13.7 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
BljygwxbKtcr$13.7 Bil
Catalent Inc
CTLT
VzxdywpjVgqgcvv$10.6 Bil
Perrigo Co PLC
PRGO
NkkgcdkLmww$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
LphjjqkvStfvnq$3.5 Bil
Curaleaf Holdings Inc
CURLF
JxdglgfrFtr$3.2 Bil

Sponsor Center